Hospira Recalls Propofol Injectable Emulsion Due to Temperature Excursions
Hospira Inc. is recalling 2,500 vials of Propofol Injectable Emulsion because the products experienced uncontrolled temperature excursions during transit.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 according to the rubric.
Plain-English summary
Hospira Inc. is recalling 2,500 vials of Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vials. The recall is due to temperature abuse, where the products experienced uncontrolled temperature excursions during transit.
The affected product is identified by Lot # 33-750-DJ with an expiration date of 1SEP2015. The distribution was limited to one shipment to The Harvard Drug Group in Livonia, MI. According to the source, these lots remained within the control of the distributor and were not further distributed.
Consumers and healthcare providers should check their inventory for this specific lot number and expiration date. If found, the product should be quarantined and not used. For further information, contact the recalling firm or the FDA.
The recalled product
- Product
- PROPOFOL (PROPOFOL)
- Brand
- PROPOFOL
- Manufacturer
- Hospira Inc.
- Category
- Drug — Injectable Anesthetic
- Hazard
- Affected units
- 2,500
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- One shipment of Lot #: 33-750-DJ
- Exp 1SEP2015 to The Harvard Drug Group
- Livonia
- MI
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by Hospira Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same brand · PROPOFOL
- CriticalPropofol Injectable Emulsion Recalled for Particulate Matter Contamination
FDA (Drugs) · 2022-09-21
- SeverePropofol Injectable Emulsion Vials Recalled for Particulate Matter Contamination
FDA (Drugs) · 2022-08-03
- SevereHospira Recalls Propofol Injectable Vials Due to Embedded Particulate Matter
FDA (Drugs) · 2015-02-04
- SevereHospira Recalls Propofol Vials Due to Metallic Particulate Matter
FDA (Drugs) · 2014-08-27
- SevereHospira Recalls Propofol Vials Due to Glass Particulate Matter
FDA (Drugs) · 2014-01-29
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recall for White Screen Safety Shutdown
FDA (Devices) · 2016-11-16
Same hazard · temperature abuse
See all →- ModerateGemcitabine Injection Recalled Due to Temperature Storage Abuse
FDA (Drugs) · 2026-07-08
- ModerateGarland Fresh peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- ModerateChristopher Ranch peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- SevereCrab Cakes Sold to Food Service Recalled for Botulism Risk
FDA (Food) · 2026-04-15
- CriticalUDENYCA syringes recalled after cartons were stored at room temperature
FDA (Drugs) · 2026-02-18